DCF — VALLEY MEDICAL CENTER
Enterprise Value: $-1.8B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.8B
Enterprise Value
$-566.0M
PV of Cash Flows
$-1.3B
PV of Terminal Value
$-2.0B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $826.6M | $-119.3M | -14.0% | $-154.3M | $-140.3M |
| Year 2 | $851.4M | $-114.4M | -13.0% | $-150.4M | $-124.3M |
| Year 3 | $876.9M | $-109.0M | -12.0% | $-146.1M | $-109.8M |
| Year 4 | $903.2M | $-107.8M | -12.0% | $-146.0M | $-99.7M |
| Year 5 | $930.3M | $-108.7M | -12.0% | $-148.1M | $-91.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.8B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$802.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1493256340324023
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5